Recognition: no theorem link
Retrieval-Augmented LLMs for Evidence Localization in Clinical Trial Recruitment from Longitudinal EHR Narratives
Pith reviewed 2026-05-10 18:52 UTC · model grok-4.3
The pith
Retrieval-augmented MedGemma reaches 89.05% micro-F1 by localizing evidence for trial eligibility in long EHR narratives.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
Generative LLMs equipped with retrieval-augmented generation localize relevant evidence segments within lengthy patient narratives more effectively than encoder-based models or unassisted long-context reading. On the 2018 N2C2 benchmark the MedGemma plus RAG combination records the highest micro-F1 of 89.05 percent. The same approach delivers its largest improvements precisely on eligibility criteria that span extended temporal reasoning across many notes, whereas criteria anchored to a single short passage improve only incrementally.
What carries the argument
Retrieval-augmented generation that dynamically pulls criterion-relevant segments from the full longitudinal EHR before feeding them to a medical-adapted generative LLM such as MedGemma, thereby mitigating the lost-in-the-middle problem.
If this is right
- Criteria that require long-term reasoning across patient histories obtain substantial accuracy gains from generative LLMs.
- Criteria limited to short contexts, such as individual lab tests, receive only incremental benefit.
- Real-world systems must select among rule-based queries, encoder models, and generative LLMs according to the specific criteria to keep compute costs reasonable.
- Automated evidence localization can reduce the manual screening burden that currently limits trial enrollment.
Where Pith is reading between the lines
- Embedding the same retrieval-plus-generation pipeline inside hospital EHR interfaces could shorten screening time enough to increase the fraction of eligible patients offered trials.
- The same evidence-localization technique may transfer to other long-document medical tasks such as extracting timelines from full patient charts or summarizing research articles for clinicians.
- Testing the pipeline on multi-institution, multi-year EHR collections that include non-English notes would reveal whether performance holds outside the benchmark distribution.
Load-bearing premise
The 2018 N2C2 Track 1 dataset and the chosen micro-F1 metric sufficiently represent the variability of real-world longitudinal EHRs and the range of eligibility criteria used in ongoing trials.
What would settle it
Re-running the MedGemma RAG pipeline on a newer collection of de-identified EHR notes drawn from currently recruiting trials and comparing its screening decisions against expert manual review would directly test whether the reported performance generalizes.
Figures
read the original abstract
Screening patients for enrollment is a well-known, labor-intensive bottleneck that leads to under-enrollment and, ultimately, trial failures. Recent breakthroughs in large language models (LLMs) offer a promising opportunity to use artificial intelligence to improve screening. This study systematically explored both encoder- and decoder-based generative LLMs for screening clinical narratives to facilitate clinical trial recruitment. We examined both general-purpose LLMs and medical-adapted LLMs and explored three strategies to alleviate the "Lost in the Middle" issue when handling long documents, including 1) Original long-context: using the default context windows of LLMs, 2) NER-based extractive summarization: converting the long document into summarizations using named entity recognition, 3) RAG: dynamic evidence retrieval based on eligibility criteria. The 2018 N2C2 Track 1 benchmark dataset is used for evaluation. Our experimental results show that the MedGemma model with the RAG strategy achieved the best micro-F1 score of 89.05%, outperforming other models. Generative LLMs have remarkably improved trial criteria that require long-term reasoning across long documents, whereas trial criteria that span a short piece of context (e.g., lab tests) show incremental improvements. The real-world adoption of LLMs for trial recruitment must consider specific criteria for selecting among rule-based queries, encoder-based LLMs, and generative LLMs to maximize efficiency within reasonable computing costs.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript presents a systematic exploration of encoder- and decoder-based generative LLMs for screening patients for clinical trial enrollment using longitudinal EHR narratives. It compares general-purpose and medical-adapted LLMs across three strategies for managing long documents—original long-context processing, NER-based extractive summarization, and RAG-based evidence retrieval—evaluated on the 2018 N2C2 Track 1 benchmark dataset. The key finding is that the MedGemma model combined with the RAG strategy achieves the highest micro-F1 score of 89.05%, with particular gains on eligibility criteria requiring long-term reasoning across documents.
Significance. If the performance claims hold and generalize beyond the specific benchmark, this work could have significant impact on reducing the labor-intensive process of clinical trial recruitment by automating evidence localization in EHRs. The differentiation between improvements on long-term vs. short-context criteria provides actionable guidance for choosing between rule-based, encoder, and generative approaches in practice, potentially improving trial enrollment rates which are currently hindered by screening bottlenecks.
major comments (2)
- [Abstract and Results] Abstract and Results: The reported best performance of 89.05% micro-F1 for MedGemma with RAG is presented without any baseline comparisons (e.g., to rule-based systems or prior SOTA on N2C2), statistical significance testing, or details on how the three strategies were implemented, which is necessary to substantiate the central performance claim.
- [Results and Discussion] Results and Discussion: The claim that 'Generative LLMs have remarkably improved trial criteria that require long-term reasoning across long documents' is load-bearing for the paper's contribution but lacks supporting evidence such as a breakdown of F1 scores by criterion type, confirmation of the longitudinal depth in the N2C2 dataset (e.g., average number of notes per patient), or error analysis showing specific gains in cross-document temporal reasoning.
minor comments (2)
- [Methods] Methods: Clarify the specific models used under 'general-purpose LLMs' and 'medical-adapted LLMs' and provide implementation details for the NER-based summarization strategy.
- [Abstract] Abstract: The abstract could benefit from mentioning the number of criteria or patients in the benchmark for context on the scale of the evaluation.
Simulated Author's Rebuttal
We thank the referee for the constructive feedback, which highlights areas where additional context and evidence will strengthen the manuscript. We address each major comment below and commit to revisions that directly respond to the concerns raised.
read point-by-point responses
-
Referee: [Abstract and Results] Abstract and Results: The reported best performance of 89.05% micro-F1 for MedGemma with RAG is presented without any baseline comparisons (e.g., to rule-based systems or prior SOTA on N2C2), statistical significance testing, or details on how the three strategies were implemented, which is necessary to substantiate the central performance claim.
Authors: We agree that the central performance claim would be more robust with explicit baselines and implementation details. In the revised manuscript, we will add a rule-based baseline using keyword and regex matching on eligibility criteria, reference the prior best-reported micro-F1 on the 2018 N2C2 Track 1 dataset, include a dedicated subsection detailing the implementation of the original long-context, NER-based summarization, and RAG strategies, and report statistical significance tests (e.g., McNemar’s test) comparing MedGemma+RAG against the other configurations. These additions will be placed in the Results and Methods sections. revision: yes
-
Referee: [Results and Discussion] Results and Discussion: The claim that 'Generative LLMs have remarkably improved trial criteria that require long-term reasoning across long documents' is load-bearing for the paper's contribution but lacks supporting evidence such as a breakdown of F1 scores by criterion type, confirmation of the longitudinal depth in the N2C2 dataset (e.g., average number of notes per patient), or error analysis showing specific gains in cross-document temporal reasoning.
Authors: We acknowledge that the claim requires quantitative backing. In the revision, we will add a table breaking down micro-F1 scores by criterion category (long-term reasoning vs. short-context criteria such as lab tests), report dataset statistics including the average number of notes per patient to confirm its longitudinal character, and include a qualitative error analysis with examples of cases where RAG improves cross-document temporal reasoning. These elements will be integrated into the Results and Discussion sections to directly support the statement. revision: yes
Circularity Check
No circularity: purely empirical evaluation on fixed public benchmark
full rationale
The paper reports measured micro-F1 scores from applying off-the-shelf and fine-tuned LLMs (including MedGemma with RAG) to the 2018 N2C2 Track 1 dataset. No equations, parameter fits, or derivations are presented; claims of improvement on long-term reasoning criteria are direct experimental outcomes on the chosen benchmark rather than quantities constructed from the model's own inputs or prior self-citations. No self-definitional loops, fitted-input-as-prediction, or load-bearing uniqueness theorems appear.
Axiom & Free-Parameter Ledger
axioms (1)
- domain assumption Named entity recognition and retrieval methods can produce faithful summaries or evidence snippets without losing critical eligibility information.
Reference graph
Works this paper leans on
-
[1]
M. H. van Velthoven, N. Mastellos, A. Majeed, J. O’Donoghue, J. Car, BMC Med. Inform. Decis. Mak. 2016, 16, DOI 10.1186/s12911-016-0332-1. [7] R. Griffiths, L. Herbert, A. Akbari, R. Bailey, J. Hollinghurst, R. Pugh, T. Szakmany, F. Torabi, R. A. Lyons, Int. J. Popul. Data Sci. 2022, 7, 1724. [8] L. Penberthy, R. Brown, F. Puma, B. Dahman, Contemp. Clin. ...
-
[2]
T. Dao, D. Y. Fu, S. Ermon, A. Rudra, C. Ré, arXiv [cs.LG] 2022. A APPENDIX Appendix Table 1. Criteria descriptions DRUG-ABUSE: Drug abuse, current or past ALCOHOL-ABUSE: Current alcohol use over weekly recommended limits ENGLISH: Patient must speak English MAKES-DECISIONS: Patient must make their own medical decisions ABDOMINAL: History of intra abdomina...
work page 2022
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.